72.11.Z - Research and experimental development on biotechnology
58.14.Z - Publishing of journals and periodicals
63.99.Z - Other information service activities not elsewhere classified
68.20.Z - Rental and operating of own or leased real estate
70.21.Z - Public relations and communication activities
70.22.Z - Business and other management consultancy activities
72.19.Z - Other research and experimental development on natural sciences and engineering
72.20.Z - Research and experimental development on social sciences and humanities
73.20.Z - Market research and public opinion polling
82.30.Z - Organisation of conventions and trade shows
2019 | 2020 | ||
---|---|---|---|
K PLN | K PLN | % | |
Assets | 21,3 | 20,7 | -2,8 |
Gross profit (loss) | -15,4 | -5,3 | 65,5 |
Net profit (loss) | -15,4 | -5,3 | 65,5 |
Cash | 7,5 | 6,9 | -8 |
Liabilities and provisions for liabilities | 185 | 189,7 | 2,6 |
Net income from sale | 0 | 0 | 0 |
Short time liabilities | 10 | 14,8 | 47,1 |
Equity capital | -163,7 | -169 | -3,3 |
Working assets | 21,3 | 20,7 | -2,8 |
Operating profit (EBIT) | -5,3 | -5,3 | 0,1 |
% | % | p.p. | |
Equity capital to total assets | -770,1 | -818,3 | -48,2 |
Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 2.1180431842803955 | 1.399599552154541 | -0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane